Stephen F. Betz - 15 Nov 2021 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Chief Scientific Officer
Signature
/s/ Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
15 Nov 2021
Net transactions value
-$193,574
Form type
4
Filing time
17 Nov 2021, 16:01:06 UTC
Previous filing
09 Nov 2021
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common stock Sale $151,619 -5,668 -3.5% $26.75 156,047 15 Nov 2021 Direct F1
transaction CRNX Common Stock Sale $41,955 -1,500 -0.96% $27.97 154,547 16 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.